METTL3, m6A modification, and EGR1: interplay affecting myocardial I/R injury outcomes
Cell Biology and Toxicology · 2024
DOI: 10.1007/s10565-024-09937-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology and Toxicology, 2024. Verfasst von Chen Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, China. Hauptthemen laut MEDLINE: Early Growth Response Protein 1, Methyltransferases, Myocardial Reperfusion Injury, Myocytes, Cardiac. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China Youth Fund.
Abstract (Originalsprache)
The occurrence of severe myocardial ischemia/reperfusion (I/R) injury is associated with the clinical application of reestablishment technique for heart disease, and understanding its underlying mechanisms is currently an urgent issue. Prior investigations have demonstrated the potential enhancement of MIRI through EGR1 suppression, although the precise underlying regulatory pathways require further elucidation. The core focus of this investigation is to examine the molecular pathways through EGR1 regulates mitophagy-mediated myocardial cell pyroptosis and its impact on MIRI. Cardiomyocyte hypoxia/reoxygenation (H/R) injury models and mouse models of myocardial I/R injury were used to investigate the involvement of EGR1 in regulating mitophagy-mediated myocardial cell pyroptosis in myocardial I/R injury. The research outcomes demonstrated that under H/R conditions, EGR1 expression was upregulated and inhibited the JAK2/STAT3 pathway, leading to enhanced mitophagy and disrupted mitochondrial fusion/fission dynamics, ultimately resulting in myocardial cell pyroptosis. Further research revealed that the upregulation of EGR1 expression was mediated by methyltransferase like 3 (METTL3)-mediated m6A modification of EGR1 mRNA and depended on the binding of insulin like growth factor 2 mrna binding protein 2 (IGF2BP2) to the N6-methyladenosine (m6A) modification site to enhance mRNA stability. In vivo animal experiments confirmed that METTL3 upregulated EGR1 expression through IGF2BP2 and suppressed activation of the janus kinase 2 (JAK2) /signal transducer and activator of transcription 3 (STAT3) pathway, thereby inhibiting mitophagy, disrupting mitochondrial dynamics, promoting myocardial cell pyroptosis, and exacerbating I/R injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, China.
- Department of Cardiovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, China. fccxuj@zzu.edu.cn.
Förderung
- National Natural Science Foundation of China Youth Fund
Zitieren
APA
Huang, C., Zhang, X., Wu, S. X., Chang, Q., Zheng, Z. K., & Xu, J. (2024). METTL3, m6A modification, and EGR1: interplay affecting myocardial I/R injury outcomes. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-024-09937-7
Vancouver
Huang C, Zhang X, Wu SX, Chang Q, Zheng ZK, Xu J. METTL3, m6A modification, and EGR1: interplay affecting myocardial I/R injury outcomes. Cell Biology and Toxicology. 2024. doi:10.1007/s10565-024-09937-7
BibTeX
@article{Huang2024,
author = {Huang, Chen and Zhang, Xun and Wu, Shi-Xiong and Chang, Qing and Zheng, Zhi-Kun and Xu, Jing},
title = {METTL3, m6A modification, and EGR1: interplay affecting myocardial I/R injury outcomes},
journal = {Cell Biology and Toxicology},
year = {2024},
doi = {10.1007/s10565-024-09937-7}
}
EUVIMED